IP Library Granted Patent US 10,441,680
Granted Patent B2
US 10,441,680 · App. 15/596,476 · Granted Oct 15, 2019

Placental tissue grafts produced by chemical dehydration/freeze-drying and methods for making and using the same

Inventors: John Daniel (Marietta, GA); Randall Spencer (Marietta, GA); Steven Ray (Marietta, GA)
Assignee: MiMedx Group, Inc.
A61L27/3604A61K35/50A61L27/3683A61L27/3687A61L27/3691A61L2430/02A61L2430/12A61L2430/16A61L2430/20A61L2430/34A61L2430/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,441,680
App. No.
15/596,476
Granted
Oct 15, 2019
Kind
B2
Abstract

Described herein are placental tissue grafts produced by chemical dehydration followed by freeze-drying the placental tissue to produce the tissue graft. The tissue grafts retain their biological properties preferably at the same level as the placental tissues before they are processed. The placental tissue grafts have numerous medical applications. Methods for making the tissue graft compositions are also described herein.

Claims (6)

1. A laminated tissue graft comprising:

a first membrane comprising modified decellularized amnion wherein the modified amnion comprises a first side and a second side, wherein the first side comprises an exposed basement membrane, and, and the second side is a decellularized fibroblast layer;

a second membrane comprising a chorion membrane layered directly adjacent to the first membrane, wherein said chorion membrane is not decellularized; and

optionally one or more additional membranes layered adjacent to the first or second membrane, wherein the one or more additional membranes is selected from the group consisting of amnion, chorion, Wharton's jelly, and combinations thereof.

2. The laminated tissue graft of claim 1 , further comprising at least one component selected from the group consisting of a naturally occurring growth factor, a platelet concentrate, a bone marrow aspirate, stem cells, and an antibiotic.

3. The laminated tissue graft of claim 1 , wherein the laminated tissue graft is dehydrated.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 10, 2018
From: DANIEL, JOHN; SPENCER, RANDALL; RAY, STEVEN
To: MIMEDX GROUP, INC.
Reel/Frame 046302/0126 →
Continuity (4)
Continuation 14932874 · Nov 4, 2015
Division 13691508 · Nov 30, 2012
Provisional Application 61566057 · Dec 2, 2011
Related Publication 20170246348A1 · Aug 31, 2017